Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

346 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.
Ginsburg SB, Algohary A, Pahwa S, Gulani V, Ponsky L, Aronen HJ, Boström PJ, Böhm M, Haynes AM, Brenner P, Delprado W, Thompson J, Pulbrock M, Taimen P, Villani R, Stricker P, Rastinehad AR, Jambor I, Madabhushi A. Ginsburg SB, et al. Among authors: brenner p. J Magn Reson Imaging. 2017 Jul;46(1):184-193. doi: 10.1002/jmri.25562. Epub 2016 Dec 19. J Magn Reson Imaging. 2017. PMID: 27990722 Free PMC article. Clinical Trial.
Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study.
Thompson JE, Moses D, Shnier R, Brenner P, Delprado W, Ponsky L, Pulbrook M, Böhm M, Haynes AM, Hayen A, Stricker PD. Thompson JE, et al. Among authors: brenner p. J Urol. 2014 Jul;192(1):67-74. doi: 10.1016/j.juro.2014.01.014. Epub 2014 Feb 8. J Urol. 2014. PMID: 24518762
Radiomic features on MRI enable risk categorization of prostate cancer patients on active surveillance: Preliminary findings.
Algohary A, Viswanath S, Shiradkar R, Ghose S, Pahwa S, Moses D, Jambor I, Shnier R, Böhm M, Haynes AM, Brenner P, Delprado W, Thompson J, Pulbrock M, Purysko AS, Verma S, Ponsky L, Stricker P, Madabhushi A. Algohary A, et al. Among authors: brenner p. J Magn Reson Imaging. 2018 Feb 22:10.1002/jmri.25983. doi: 10.1002/jmri.25983. Online ahead of print. J Magn Reson Imaging. 2018. PMID: 29469937 Free PMC article.
Predicting Low-Risk Prostate Cancer from Transperineal Saturation Biopsies.
van Leeuwen PJ, Siriwardana A, Roobol M, Ting F, Nieboer D, Thompson J, Delprado W, Haynes AM, Brenner P, Stricker P. van Leeuwen PJ, et al. Among authors: brenner p. Prostate Cancer. 2016;2016:7105678. doi: 10.1155/2016/7105678. Epub 2016 Apr 11. Prostate Cancer. 2016. PMID: 27148459 Free PMC article.
The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies.
Amin A, Scheltema MJ, Shnier R, Blazevski A, Moses D, Cusick T, Siriwardena A, Yuen B, van Leeuwen PJ, Haynes AM, Matthews J, Brenner P, O'Neill G, Yuen C, Delprado W, Stricker P, Thompson J. Amin A, et al. Among authors: brenner p. J Urol. 2020 May;203(5):910-917. doi: 10.1097/JU.0000000000000693. Epub 2019 Dec 11. J Urol. 2020. PMID: 31825297 Clinical Trial.
Final Analysis of the Magnetic Resonance Imaging in Active Surveillance Trial.
Doan P, Scheltema MJ, Amin A, Shnier R, Geboers B, Gondoputro W, Moses D, van Leeuwen PJ, Haynes AM, Matthews J, Brenner P, O'Neill G, Yuen C, Delprado W, Stricker P, Thompson J. Doan P, et al. Among authors: brenner p. J Urol. 2022 Nov;208(5):1028-1036. doi: 10.1097/JU.0000000000002885. Epub 2022 Aug 10. J Urol. 2022. PMID: 35947521 Clinical Trial.
346 results